Deoxypyridinoline

Deoxypyridinoline (also known as DPD) is a biochemical marker used in the medical field to measure the rate of bone resorption. It can be found in urine and blood tests and is useful in the diagnosis and management of various bone diseases, including osteoporosis and some cancers.

Overview

Deoxypyridinoline is a pyridinium cross-linking amino acid that is released during the breakdown of collagen, which is a major component of bone. The level of DPD in the body can provide insight into the rate at which bone is being broken down, which can be an indicator of bone disease.

Clinical Significance

The measurement of DPD is often used in the diagnosis and management of diseases that affect bone metabolism, such as osteoporosis and Paget's disease. It can also be used to monitor the effectiveness of treatment for these conditions.

In addition, elevated levels of DPD can be seen in certain types of cancer that spread to the bone, such as breast cancer and prostate cancer. In these cases, the measurement of DPD can help to assess the extent of the disease and the effectiveness of treatment.

Measurement

DPD is typically measured in urine, although it can also be measured in blood. The test is usually performed in a laboratory and involves the use of a special chemical that reacts with DPD to produce a color change. The intensity of the color change is then measured to determine the level of DPD in the sample.

Limitations

While the measurement of DPD can provide valuable information about bone metabolism, it is not a definitive test for any particular disease. It is usually used in conjunction with other tests and clinical information to make a diagnosis.

See Also

• Bone metabolism
• Osteoporosis
• Paget's disease
• Breast cancer
• Prostate cancer

References

Deoxypyridinoline Resources
Latest articles Most recent articles Ongoing trials	Wikipedia